1033780-34-5 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 11 carbon (C) atoms, 11 hydrogen (H) atoms, and 5 nitrogen (N) atoms.
Explanation
The structure describes the arrangement of atoms in the molecule. 1-(pyridin-3-ylmethyl)-1H-pyrazol-3-amine has a pyrazole ring (a five-membered ring with two nitrogen atoms and three carbon atoms) with an amine group (-NH2) and a pyridine ring (a six-membered ring with one nitrogen atom) attached to it.
3. Heterocyclic organic compound
4. Derivative of pyrazole
Explanation
The compound is derived from pyrazole, which is a heterocyclic organic compound. The presence of additional functional groups, such as the amine group and the pyridine ring, differentiates 1-(pyridin-3-ylmethyl)-1H-pyrazol-3-amine from the parent pyrazole structure.
Explanation
The presence of the amine group and the pyridine ring in the compound's structure suggests that it may have biological activity, which could be useful in the development of drugs or other biologically active molecules.
7. Building block for synthesis
Explanation
The compound's structure makes it a potential building block for the synthesis of more complex molecules, which could be used for various scientific and industrial purposes, such as the development of new drugs or materials.
Structure
1-(pyridin-3-ylmethyl)-1H-pyrazol-3-amine
Potential applications
Pharmaceuticals or agrochemicals
6. Biological activity
Check Digit Verification of cas no
The CAS Registry Mumber 1033780-34-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,3,7,8 and 0 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1033780-34:
(9*1)+(8*0)+(7*3)+(6*3)+(5*7)+(4*8)+(3*0)+(2*3)+(1*4)=125
125 % 10 = 5
So 1033780-34-5 is a valid CAS Registry Number.
1033780-34-5Relevant academic research and scientific papers
CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES
-
Page/Page column 62, (2009/10/21)
Novel heterocyclic compounds of the formula (I) wherein D is formula (A) or formula (B) wherein R1, R2, E', E'', E''', Y'', Y'', G', G'', G''' and G''' have the meaning of claim 1, are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy.
